Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Arbutus Biopharma Corp Transaction History
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
- $92.2 Billion
- Q3 2024
A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 81,947 shares of ABUS stock, worth $272,883. This represents 0.0% of its overall portfolio holdings.
Number of Shares
81,947
Previous 89,695
8.64%
Holding current value
$272,883
Previous $277,000
13.72%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ABUS
# of Institutions
163Shares Held
99.6MCall Options Held
2.31MPut Options Held
525K-
Morgan Stanley New York, NY21.7MShares$72.3 Million0.01% of portfolio
-
Whitefort Capital Management, LP New York, NY12.9MShares$42.9 Million26.34% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$38.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.98MShares$29.9 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY8.39MShares$27.9 Million10.86% of portfolio
About Arbutus Biopharma Corp
- Ticker ABUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,951,008
- Market Cap $499M
- Description
- Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...